Načítá se...
Niacin increases atherogenic proteins in HDL of statin-treated subjects
OBJECTIVE –: Niacin therapy fails to reduce cardiovascular events in statin-treated subjects even though it increases plasma HDL cholesterol (HDL-C) and decreases LDL-C and triglyceride levels. To investigate potential mechanisms for this lack of cardioprotection, we quantified the HDL proteome of s...
Uloženo v:
| Vydáno v: | Arterioscler Thromb Vasc Biol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295224/ https://ncbi.nlm.nih.gov/pubmed/34134520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.121.316278 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|